📰 Markwin Velders News
Markwin Velders News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Markwin Velders. Real-time updates on events, politics, business and more.
March 1, 2022
- Patient data from higher dose cNeT as monotherapy and cNeT in combination with checkpoint inhibitor expected in 2H 2022 - - Strong cash position of $266 million supports clinical development and
March 1, 2022
Investegate announcements from Syncona Limited, Achilles reports Full Year 2021 Results
August 10, 2021
Investegate announcements from Syncona Limited, Achilles reports Second Quarter 2021 Results
August 10, 2021
Investegate announcements from Achilles Therapeutics PLC, Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights
August 10, 2021
- Presentations of translational science data at AACR and ASCO illustrate crucial path to potency assay - - Data from ten patients across CHIRON and THETIS studies anticipated in the fourth quarter
May 11, 2021
- Reported first clinical data from the CHIRON and THETIS trials and received recommendation from the Independent Data Safety Monitoring Committee to continue trials as planned - London, UK 11 May 2021 - Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced its financial results for the first quarter ended March 31, 2021 and recent business...
May 3, 2021
Investegate announcements from Achilles Therapeutics PLC, Achilles Therapeutics Appoints Julie O’Neill to Board of Directors and Markwin Velders, Ph.D. joins Scientific Advisory Board